Stem Cell Firms Not Bargaining on IP From Strong Position
Venture capitalists are like cloned sheep. That is one basic reason that embryonic stem cell research is not being funded.
Or so it seems, based on an article by Terri Somers in the San Diego Union-Tribune. Her piece illustrated the weakness of the position of businesses now trying to influence the formulation of intellectual property policies by the Ca…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.